Post

Oncternal doses first patient in trial of B cell lymphoma therapy

Oncternal Therapeutics has dosed the first patient in its Phase I/II trial of ONCT-808, a ROR1 targeting autologous CAR T …

LianBio reports positive topline data from gastric cancer therapy trial

LianBio has reported positive topline results from a Phase IIa trial of infigratinib for the treatment of locally advanced or …

QurAlis receives authorisation to initiate ALS therapy trial in EU

QurAlis has received clinical trial authorisation (CTA) in the European Union (EU) to initiate a first-in-human, Phase I ANQUR clinical …

BPGbio doses first patients in Phase II GBM therapy trial

BPGbio has dosed the first patients in a Phase II clinical trial of BPM 31510 to treat Glioblastoma Multiforme (GBM), …

ASCO 2023: blockbuster Enhertu demonstrates efficacy across multiple tumour types

At the American Society of Clinical Oncology (ASCO) Annual Meeting, 2-6 June 2023, interim results were presented for the Phase …